$31.75
+2.96 (+10.28%)
USD · as of 2026-08-14 · marketstack
| P/E (FY) | — | Sales (TTM) | — |
| Earnings (TTM) | — | ROE | — |
| Net Margin | — | ROIC | — |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | — |
| Market Cap | — | Trading Days | 11 |
| 52W High | 33.09 |
| 52W Low | 16.12 |
| % Off High | −4.06% |
| Ann. Volatility (1Y) | 97.79% | Ann. Volatility (3Y) | 97.79% |
| Sharpe (1Y) | 6.68 | Sharpe (3Y) | 6.68 |
| Max Drawdown (1Y) | −10.99% | Max Drawdown (3Y) | −10.99% |
| YTD | 27.00% | Since inception | 27.00% |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| LLY | ELI LILLY & Co | $1.11T | 51.4 |
| JNJ | JOHNSON & JOHNSON | $627.42B | 23.6 |
| ONC | BeOne Medicines Ltd. | $513.62B | 1828.8 |
| ABBV | AbbVie Inc. | $440.83B | 105.7 |
| MRK | Merck & Co., Inc. | $335.14B | 18.7 |
| ABT | ABBOTT LABORATORIES | $193.78B | 29.9 |
| PFE | PFIZER INC | $152.69B | 19.7 |
| BMY | BRISTOL MYERS SQUIBB CO | $130.39B | 18.4 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | $128.19B | 33.0 |
| REGN | REGENERON PHARMACEUTICALS, INC. | $75.49B | 19.4 |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | $42.85B | 30.4 |
| RPRX | Royalty Pharma plc | $33.08B | 32.9 |